Bromocriptine

Bromocriptine: Patient Information for Australia

Basic Product Information

What Is Bromocriptine?

Bromocriptine is a medication used primarily to treat conditions related to high levels of the hormone prolactin, Parkinson’s disease, and certain menstrual, fertility, and hormonal disorders. It is classed as a dopamine agonist, meaning it works by mimicking the action of the body’s natural chemical messenger dopamine.

How Bromocriptine Works

For the General Public

Bromocriptine helps regulate various body functions by acting similarly to dopamine, a natural brain chemical. By doing so, it reduces the release of prolactin (a hormone involved in milk production and menstrual cycles), and helps balance other hormonal and neurological functions.

For Healthcare Professionals/Specialists

Bromocriptine is a semi-synthetic ergot alkaloid derivative acting as a potent dopamine D2 receptor agonist, with lesser activity at D1 receptors and serotonergic/adrenergic sites. Its primary actions are inhibition of anterior pituitary prolactin secretion and modulation of nigrostriatal dopaminergic activity.

Pharmacokinetics

• Absorption: Rapid, but variable oral bioavailability (approximately 28%) due to extensive first-pass hepatic metabolism.
• Metabolism: Mainly hepatically metabolised by cytochrome P450 enzymes (CYP3A4).
• Elimination: Primarily via faeces (60%, as metabolites), small amounts in urine.
• Time to Peak Plasma: 1–3 hours after ingestion.
• Half-life: About 12–15 hours (extended in advanced liver impairment).
• Duration of Action: Prolactin suppression may last up to 24 hours per dose.

Practical Use in Everyday Life

• Typical Adult Dose Range: 1.25–2.5 mg daily, slowly increased as tolerated up to 5–30 mg/day depending on condition.
• Bromocriptine is best taken with food or just after a meal to reduce the chance of feeling nauseous.
• Tablets should be taken whole with water, at the same time each day to promote routine and effectiveness.
• Alcohol should be limited as it may increase side effects such as drowsiness or dizziness.
• Important: Never suddenly stop this medicine without consulting your doctor or pharmacist, especially in Parkinson’s disease.

Dosing: Morning vs. Evening

• Morning dosing may help avoid sleep disturbances but may increase early-day side effects like nausea or dizziness. It’s preferred if the patient experiences insomnia or vivid dreams.
• Evening dosing may suit people who feel drowsy after bromocriptine or wish to sleep through initial side effects.
• Split dosing (morning + evening) is sometimes used for higher doses or to minimise side effects.
• Tip: Establish a regular pattern and stick to it, coordinating with meals for best tolerance.

Taking Bromocriptine with Food – Australian Dietary Habits

Bromocriptine is absorbed more consistently and is less likely to upset your stomach when taken with food. Australians often take medications with breakfast or dinner. Try to align your tablets with a main meal or a light snack, and avoid taking on a completely empty stomach.

Interactions: Food, Alcohol, and Medications

Indications for Bromocriptine

Dosing According to Clinical Indication

Safety Profile and Side Effects

• Most Common Side Effects:
  • Nausea, vomiting
  • Dizziness, headache or light-headedness (especially when standing quickly)
  • Fatigue, drowsiness
  • Disturbed sleep or vivid dreams
  • Constipation
• Less Common/Rare Side Effects:
  • Confusion, hallucinations (mainly in elderly or high doses)
  • Raynaud’s phenomenon (cold, pale hands/feet)
  • Low blood pressure or fainting
  • Heart valve changes (rare, with extended use or high doses)
  • Impulse control disorders (gambling, shopping, etc.)
• Serious Warnings:
  • Sudden sleep attacks
  • Unexplained shortness of breath or chest pain (see GP immediately)
  • Unusual swelling, severe nausea, vomiting, confusion – seek urgent medical advice

Advice for Proper Use – Tips from Your Australian Pharmacist

• Always take bromocriptine exactly as directed by your doctor and pharmacist; do not change your dose yourself.
• Rise slowly from sitting/lying positions to avoid dizziness or fainting.
• If you miss a dose, take it as soon as you remember. If it’s nearly time for your next dose, skip the missed dose – do not double up.
• Let your GP or specialist know if you plan to stop the medicine, especially if you’ve been on high doses or taking it long-term.
• Regular blood pressure and heart checks are recommended during treatment.
• Carry an up-to-date medicines list, especially if travelling within Australia.

Alternative Treatment Options

• Cabergoline (Dostinex®) – Longer-acting, usually better tolerated for hyperprolactinaemia; once or twice weekly dosing.
• Quinagolide (not currently listed in Australia).
• Levodopa/Carbidopa (Sinemet®, Kinson®) – Mainstay for Parkinson's disease; may be used with or instead of bromocriptine.
• Somatostatin analogues (e.g. octreotide) – For acromegaly; injectables, often for more severe disease.
• Non-drug options: Surgery or radiotherapy (for tumours or acromegaly), where appropriate.

Pros & Cons Overview: Cabergoline is generally preferred for prolactin-related conditions due to fewer side effects and greater convenience. Bromocriptine remains a cost-effective and proven alternative, especially when cabergoline is not tolerated or suitable.

Legal, Registration & Reimbursement Status (Australia)

• Registered with the TGA (Therapeutic Goods Administration).
• Prescription only (Schedule 4; S4).
• Listed on the PBS (Pharmaceutical Benefits Scheme) for most approved indications (e.g. prolactinoma, Parkinson’s disease, acromegaly).
• Reimbursement: Eligible patients pay only the PBS co-payment (subject to concession and general rates).
• Supply only from registered Australian pharmacies with a valid prescription.

Latest Research & Clinical Guidance (2022–2025)

• 2024 Endocrine Society Guidelines support cabergoline as first-line in prolactinomas, but bromocriptine remains important for patients intolerant to cabergoline, and during pregnancy (Endocrine Society, 2024).
• Recent Australian PBS data confirms ongoing cost-effectiveness and utility of bromocriptine as an adjunct in Parkinson’s disease, especially for younger patients and those with intolerance to other dopamine agonists.
• International Parkinson and Movement Disorder Society recommends careful titration of bromocriptine due to risk of impulse control disorders (MDS, 2022).
• Ongoing safety monitoring has reinforced the rare but important risks of cardiac valvulopathy—regular cardiac monitoring is advised with long-term/high-dose use.

Availability & Delivery in Australia

*PBS price as of January 2024; actual private prices may vary. **Via Australia Post/pharmacy courier services.

Frequently Asked Questions (FAQ)

1. How long does bromocriptine take to work?
   Some effects (such as lowering prolactin) can be seen within days to two weeks. For Parkinson’s or acromegaly, it may take several weeks to notice full benefits as doses are gradually increased.
2. What if I feel nauseous or dizzy?
   These are common side effects, especially when starting. Take each dose with food, rise slowly from chairs/bed, and speak to your pharmacist or doctor if this persists.
3. Will bromocriptine interact with my other medicines?
   Bromocriptine can interact with some medicines (such as blood pressure tablets, some antibiotics, and other dopamine-related drugs). Always inform your pharmacist and GP of all medicines and supplements you take.
4. Can I drink alcohol while using bromocriptine?
   It’s best to limit alcohol with bromocriptine, as it can increase the risk of low blood pressure or drowsiness.
5. Is bromocriptine safe during pregnancy?
   For some hormonal conditions, bromocriptine is continued during early pregnancy, but always discuss plans for pregnancy or breastfeeding with your doctor, as specialist advice is needed.

Always seek medical advice before starting or stopping any medicines, and report side effects to your doctor or pharmacist.